Do vaccines modify the prevalence of asthma and allergies?

Expert Review of Vaccines

Volumn 5, Issue 5, 2006, Pages 631-640

  Sánchez Solis, Manuel ^a   García Marcos, Luis ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Allergy; Asthma; Atopy; Eczema; Hayfever; Hygiene hypothesis; Immunization; Vaccines

Indexed keywords

ACELLULAR VACCINE; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; BCG VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; METHACHOLINE; MYCOBACTERIUM VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PLACEBO; POLIOMYELITIS VACCINE; SMALLPOX VACCINE; TETANUS TOXOID;

AGE DISTRIBUTION; ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG MECHANISM; EARLY CHILDHOOD INTERVENTION; ECZEMA; HAY FEVER; HUMAN; IMMUNIZATION; LUNG TUBERCULOSIS; MEASLES; MYCOBACTERIOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOCONJUNCTIVITIS; RISK ASSESSMENT; TUBERCULIN TEST; WHEEZING;

ASTHMA; BCG VACCINE; COMMUNICABLE DISEASES; EUROPE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; MEASLES-MUMPS-RUBELLA VACCINE; PERTUSSIS VACCINE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VACCINES;

EID: 33845868218     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.5.5.631     Document Type: Review

References (69)

1. Krämer U, Heinrich J, Wjst M, Wichmann HE. Age of entry to day nursery and allergy in later childhood. Lancet 353(9151), 450-454 (1999).
2. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N. Engl. J. Med. 343(8), 644-650 (2000).
3. Braun-Fahrländer C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347(12), 869-877 (2002).
4. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 275(5296), 77-79 (1997) •• First report relating childhood infections with allergies.
5. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 112(3), 352-363 (2004).
6. Townley RG, Barlan IB, Patino C et al. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann. Allergy Asthma Immunol. 92(3), 350-355 (2004).
7. Anlar FY, Kabasakalb E, Karsi R. Tuberculosis and atopy: a study in an endemic area. Resp. Med. 100(9), 1647-1650 (2006) (Epub) doi:10.1016/j.rmed.
8. Obihara CC, Beyers N, Gie RP et al. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children. Allergy 60(9), 1121-1125 (2005).
9. Obihara CC, Marais BJ, Gie RP et al. The association of prolonged breastfeeding and allergic disease in poor urban children. Eur. Respir. J. 25(6), 970-977 (2005).
10. Annus T, Montgomery SM, Riikjärv MA, Björksten B. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 59(10), 1068-1073 (2004). • Reports that the risk of atopy, allergic rhinitis or asthma was not associated with the age of Bacillus Calmette-Guérin (BCG) vaccination.
11. Omenaas E, Jentoft HF, Vollmer WM, Buist AS, Gulsvik A. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 55(6), 454-458 (2000).
12. 1 and bronchial hyperresponsiveness in BCG vaccinated young adults. Allergy 57(4), 336-340 (2002).
13. Cooper PJ, Chico ME, Rodrigues LC et al. Risk factors for atopy among school children in a rural area of Latin America. Clin. Exp. Allergy 34(6), 845-852 (2004).
14. Ota MOC, van der Sande MAB, Walraven GEL et al. Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia. Clin. Exp. Allergy 33(6), 731-736 (2003).
15. Wong GW, Hui DS, Tam CM et al. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong. Thorax 56(10), 770-773 (2001).
16. Yilmaz M, Bingöl G, Altintas D, Kendirli SG. Correlation between atopic diseases and tuberculin responses. Allergy 55(7), 664-667 (2000).
17. Von Mutius E, Pearce N, Beasely R et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rinithis and eczema. Thorax 55(6), 449-453 (2000).
18. Shirtcliffe P, Weatherall M, Beasely R. International study of asthma and allergies in childhood. An inverse correlation between estimated notification rates and asthma symptoms. Respirology 7(2), 153-155 (2002).
19. von Hertzen L, Klaukka T, Mattila H, Haatela T. Mycobacterium tuberculosis infection and the subsequent development af asthma and allergic conditions. J. Allergy Clin. Immunol. 104(6), 1211-1214 (1999).
20. Mungan D, Sin BA, Celik G, Gurkan OU, Acican T, Misirligil Z. Atopic status of an adult population with active and inactive tuberculosis. Allergy Asthma Proc. 22(2), 87-91 (2001).
21. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 350(9075), 400-403 (1997).
22. Aaby P, Shaheen O, Heyes CB et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy 30(5), 644-650 (2000).
23. Grüber C, Meinlschmidt G, Bergmann R, Wahn U, Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr. Allergy Immunol. 13(3), 177-181 (2002). •• The larger epidemiological study about the relationship between BCG vaccine and atopy. The authors found a weak but significant protective effect.
24. Marks GB, Ng K, Zhou J et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J. Allergy Clin. Immunol. 111(3), 541-549 (2003).
25. Bager P, Rostgaard K, Nielsen NM, Melbye M, Westergaad T. Age at Bacille Calmette-Guérin vaccination and risk of allergy and asthma. Clin. Exp. Allergy 33(11), 1512-1517 (2003). • Describes the risk of atopy, allergic rhinitis or asthma as not being associated with the age at BCG vaccination.
26. Krause TG, Hviid A, Koch A et al. BCG vaccination and risk of atopy. JAMA 289(8), 1012-1015 (2003).
27. Mommers M, Weishoff-Houben M, Swaen GMH et al. Infant immunization and the occurrence of atopic disease in Dutch and German children. Pediatr. Pulmonol. 38(4), 329-334 (2004).
28. García-Marcos L, Morales Suárez-Varela M, Miner Canflanca I et al. BCG immunization at birth and atopic diseases in a homogeneous population of spanish schoolchildren. Int. Arch. Allergy Immunol. 137(4), 303-309 (2005). •• Report comparing two large homogenous populations (BCG-vaccinated vs BCG-nonvaccinated) showing a weak but significant protective effect.
29. Grüber C, Kulig M, Bergmann R, Guggenmoos-Holzmann I,Wahn U, The MAS-90 Study Group. Delayed hypersensitivity to tuberculin, total immunoglubulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Guérin-vaccinated and nonvaccinated children. Pediatrics 107(3), e36 (2001).
30. Strannegard IL, Larsson LO, Wennergren G, Strannergard Ö. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53(3), 249-254 (1998).
31. Smit JJ, Folkerts G, Nijkamp FP. Mycobacteria, genes and the 'hygiene hypothesis'. Curr. Opin. Allergy Clin. Immunol. 4(1), 57-62 (2004).
32. Vargas MH, Bernal-Alcántara DA, Vaca MA, Franco-Marina F, Lascurain R. Effect of BCG vaccination in asthmatic schoolchildren Pediatr. Allergy Immunol. 15(5), 415-420 (2004). • A clinical trial in which asthmatic children were vaccinated with BCG and were evaluated during one year of follow-up. The authors found no beneficial effect.
33. Tsai JJ, Peng HJ, Shen HD. Therapeutic effect of Bacillus Calmette-Guérin with allergen on human allergic asthmatic patients. J. Microbiol. Immunol. Infect. 35(2), 99-102 (2002). • A clinical trial conducted to evaluate the therapeutic effect of BCG vaccination in asthmatic adults, in which no beneficial effects were found.
34. Shirtcliffe PM, Easthope SE, Weatherall M, Beasleyz R. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis Bacillus Calmette-Guérin in adult asthma. Clin. Exp. Allergy 34(2), 207-212 (2004).
35. Smit JJ, Van Loverenw H, Hoekstraz MO et al. Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin. Exp. Allergy 33(5), 1083-1089 (2003).
36. Shirtcliffe PM, Goldkorn A, Weatherall M, Tan PLJ, Beasley R. Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. Respirology 8(4), 497-503 (2003).
37. Shirtcliffe PM, Easthope SE, Cheng S et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am. J. Respir. Crit. Care Med. 163(6), 1410-1414 (2001).
38. Pauwels R, van der Straeten M, Platteau B, Bazin H. The non-specific enhacement of allergy, I: in vivo effects of Bordetella pertussis vaccine on IgE synthesis. Allergy 38(4), 239-246 (1983).
39. Munoz JJ, Peacock MG. Action of pertussigen (pertussis toxin) on serum IgE and on Fc ε receptors on lymphocytes. Cell Immunol. 127(2), 327-336 (1990).
40. Hedenskog S, Björksten B, Blennow M, Granström G, Granström M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole cell and an acellular pertussis vaccine. Int. Arch. Allergy Immunol. 89(2), 156-161 (1989).
41. Odelram H, Granström M, Hedenskog S, Duchen K, Björksten B. Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines. Pediatr. Allergy Immunol. 5(2), 118-123 (1994).
42. Nilsson L, Grüber C, Granström M, Björkstén B, Kjellman NIM. Pertussis IgE and atopic disease. Allergy 53(12), 1195-1201 (1998).
43. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 20(Suppl. 3), S34-S39 (2002).
44. Odent MR, Culpin EE, Kimmel T. Pertussis vaccination and asthma: is there a link? JAMA 272(8), 592-593 (1994).
45. Kemp T, Pearce N, Fitzharris P et al. Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology 8(6), 678-680 (1997).
46. Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax 53(11), 927-932 (1998).
47. Nilsson L, Kjellman NIM, Björkstén B. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch. Pediatr. Adolesc. Med. 152(8), 734-738 (1998). • A prospective study evaluating the effects of acellular and whole-cell pertussis vaccines. Results indicated a possible small increase in the risk of atopic disease after acellular pertussis vaccination at 2.5 years of age.
48. Nilsson L, Kjellman NI, Bjorksten B. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of vaccines. Arch. Pediatr. Adolesc. Med. 157(12), 1184-1189 (2003). • A prospective study evaluating the effect of acellular and whole-cell pertussis vaccines at 7 years of age. There was no association between this vaccination (acellular or whole-cell) and the prevalence of asthma, allergic rhinoconjuntivitis, atopic dermatitis or any allergic disease at this age.
49. Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Björstén B, Asher MI, ISAAC Phase I study group. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am. J. Public Health 91(7), 1126-1129 (2001). •• Ecological study including more than 400,000 children that found an inverse relationship between the rates of diphtheria, tetanus and pertussis immunization and the prevalence of atopic diseases throughout the world.
50. DeStefano F, Gu D, Kramarz P et al. Vaccine safety datalink research group childhood vaccinations and risk of asthma. Pediatr. Infect. Dis. J. 21(6), 498-504 (2002). •• An extensive study in which a cohort of 167,000 children were followed: no differences on asthma prevalence among vaccinated and nonvaccinated children were found.
51. Bernsen RMD, de Jongste JC, van der Wouden JC. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur. Respir. J. 22(6), 962-964 (2003).
52. Maher JE, Mullooly JP, Drew L, DeStefano F. Infant vaccinations and childhood asthma among full-term infants. Pharmacoepidemiol. Drug Saf. 13(1), 1-9 (2004). • A cohort study that reports that childhood asthma was not significantly associated with the number of doses of whole-cell pertussis vaccine and that the measles-mumps-rubella vaccine was not associated with an increase in the prevalence of asthma.
53. Bremner SA, Carey IM, DeWilde S et al. Timing of routine immunisations and subsequent hayfever risk. Arch. Dis. Child 90(6), 567-573 (2005).
54. Wickens K, Crane J, Kemp T et al. A case-control study of risk factors for asthma in New Zealand children. Aust. NZ J. Public Health 25(1), 44-49 (2001).
55. Bremner SA, Carey IM, DeWilde S et al. Timing of routine immunisations and subsequent hayfever risk. Arch. Dis. Child. 90(6), 567-573 (2005).
56. Mullooly JP, Pearson J, Drew L et al.. Wheezing lower respiratory disease and vaccination of full-term infants. Pharmacoepidemiol. Drug Saf. 11(1), 21-30 (2002).
57. Roost HP, Gassner M, Grize L et al. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Pediatr. Allergy Immunol. 15(5), 401-407 (2004). • Describes an inverse association between asthma and a positive disease history or vaccination against measles.
58. Bager P, Westergaard T, Rostgaard K, Nielsen NM, Melbye M, Aaby P. Smallpox vaccination and risk of allergy and asthma. J. Allergy Clin. Immunol. 111(6), 1227-1231 (2003). • The only article reporting the relationship between smallpox vaccine and atopic disorders.
59. Bernsen RMD, Koes BW, de Jongste JC, van der Wouden JC. Haemophilus influenzae type b vaccination and reported atopic disorders in 8-12-year-old children. Pediatr. Pulmonol. 41(5), 463-469 (2006).
60. Laubereau B, Grote V, Holscher G et al. Vaccination against Haemophilus influenzae type b and atopy in east German schoolchildren. Eur. J. Med. Res. 7(9), 387-392 (2002).
61. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 353(9163), 1485-1488 (1999).
62. Flöistrup H, Swartz J, Bergström A et al. Allergic disease and sensitization in Steiner school children. J. Allergy Clin. Immunol. 117(1), 59-66 (2006).
63. Grüber C, Illi S, Lau S et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 111(3), e282-e288(2003).
64. Martignon G, Oryszczyn MP, Annesi-Maesano I. Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatr. Allergy Immunol. 16(3), 193-200 (2005).
65. Enriquez R, Addington W, Davis F et al. The relationship between vaccine refusal and selfreport of atopic disease in children. J. Allergy Clin. Immunol. 115(4), 737-744 (2005).
66. Offit PA, Hackett CJ Addressing parents' concerns: do vaccines cause allergic or autoimmune diseases? Pediatrics 111(3), 653-659 (2003).
67. Koppen S, de Groot R, Neijens HJ et al. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 22(25-26), 3375-3385 (2004). • An excellent review on the topic.
68. Lewis SA, Britton JR. Measles infection, measles vaccination and the effect of birth order in the aetiology of hayfever. Clin. Exp. Allergy 28(12), 1493-1500 (1998). •• A study based on a British birth-cohort that explored the independent effect of measles infection and measles vaccination on the occurrence of hayfever. The authors concluded that in those children with contact with older siblings, hayfever was reduced significantly and independently in relation to both measles infection and measles vaccination, compared with those who were neither infected nor vaccinated.
69. Bager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M. Age at childhood infections and risk of atopy. Thorax 57(5), 379-382 (2002).